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Summary
The molecular mechanisms by which liver genes are
differentially expressed along a portocentral axis,
allowing for metabolic zonation, are poorly under-
stood. We provide here compelling evidence that the
Wnt/b-catenin pathway plays a key role in liver zona-
tion. First, we show the complementary localization
of activated b-catenin in the perivenous area and the
negative regulator Apc in periportal hepatocytes. We
then analyzed the immediate consequences of either
a liver-inducible Apc disruption or a blockade of Wnt
signaling after infection with an adenovirus encoding
Dkk1, and we show that Wnt/b-catenin signaling in-
versely controls the perivenous and periportal genetic
programs. Finally, we show that genes involved in the
periportal urea cycle and the perivenous glutamine
synthesis systems are critical targets of b-catenin sig-
naling, and that perturbations to ammoniametabolism
are likely responsible for the death of mice with liver-
targeted Apc loss. From our results, we propose that
Apc is the liver ‘‘zonation-keeper’’ gene.
Introduction
The liver is organized to fulfill its metabolic purpose,
which is to receive and remove raw materials from the
intestine, and to biotransform, synthesize, and secrete
manufactured products that are delivered to the sys-
*Correspondence: perret@cochin.inserm.frtemic circulation via the hepatic vein and to the intestine
via the bile ducts. Consequently, liver functions are
compartmentalized in the hepatic lobule within the liver
cell plate. This functional unit of hepatic parenchyma is
the area of tissue (15–25 hepatocytes) in which all liver
cells receive blood from a common final vessel. The first
row of periportal (PP) hepatocytes, surrounding the
portal space (ps), receives a mixture of blood from both
the hepatic artery and the portal vein and is in contact
with the bile ducts. On the opposite side of the liver cell
plate, the centrilobular hepatocytes surround a hepatic
centrilobular vein (cv) and are called perivenous (PV)
hepatocytes. This portocentral axis is the basis for
the metabolic liver zonation.
Carbohydrate metabolism, the removal of ammonia,
bile formation, transport and secretion, and drug bio-
transformation are the classical zonated functions of
the liver. The proteins involved in these functions are
also compartmentalized, and in view of evidence of the
localization of some key enzymes in the lobule, the PP
and the PV areas should each be further subdivided
into a proximal and a distal part (Jungermann and Kietz-
mann, 1996, 2000). The molecular basis for these zona-
tions remains unclear: some zonated protein expression
is static and is only under transcriptional control, such
as that of glutamine synthetase (GS) related to ammonia
detoxification, whereas zonated protein expression
related to carbohydrate and xenobiotic metabolisms is
dynamic and depends on environmental factors such
as oxygen or hormone or nutrient gradients and can
be controlled at a transcriptional or posttranscriptional
level (Gebhardt and Gaunitz, 1997; Oinonen and Lindros,
1998). Even when static transcriptional control of com-
partmentalized expression has been proposed, no ma-
jor transcription factor was implicated; thus, the molec-
ular pathways involved in liver zonation still need to be
identified (Lindros et al., 1997).
Inappropriate b-catenin signaling has been found in
30%–40% of human hepatocellular carcinomas (HCCs)
(see de La Coste et al., 1998 and Giles et al., 2003 for a re-
view). The general signaling scheme for this is the fol-
lowing: in the absence of Wnt signals and without any
b-catenin-dependent oncogenic process, a degradation
complex containing the products of the tumor suppres-
sor genes APC (adenomatous polyposis coli) as well as
axins and the kinases GSK-3b and CK1 allows b-catenin
to be phosphorylated and tagged for degradation. In this
case, b-catenin remains at the membrane of the hepato-
cyte and participates in an adhesion complex with cad-
herins. Wnt/b-catenin signaling may be activated either
by Wnt-soluble proteins binding to frizzled receptors
or by oncogenic activation due primarily to b-catenin
mutations in human HCCs, which leads to the b-catenin
degradation complex being disrupted and the un-
phosphorylated b-catenin being stabilized. This stable
b-catenin binds to members of the Tcf-Lef family of tran-
scription factors and activates Wnt-dependent gene
transcription.
In previous studies, we have shown that activating a
b-catenin signal in mouse liver is oncogenic (Colnot
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of the b-catenin pathway in more than 70% of hepato-
cytes in mice, either by expressing a constitutively on-
cogenic form of b-catenin (Cadoret et al., 2002; Ovejero
et al., 2004) or by disrupting a negative regulator of the
pathway, that is, the Apc gene (Colnot et al., 2004a),
killed the mice within 2 weeks, after a dramatic hepato-
megaly. We identified several positive b-catenin liver-
specific target genes (Cadoret et al., 2002; Ovejero
et al., 2004). These target genes, which encode gluta-
mine synthetase (GS), transporter-1 of glutamate
(Glt1), ornithine aminotransferase (Oat), and leukocyte
cell-derived chemotaxin-2 (Lect2), had all been de-
scribed as being exclusively physiologically expressed
by the proximal PV hepatocytes (Cadoret et al., 2002;
Kuo et al., 1991; Moorman et al., 1988; Ovejero et al.,
2004), whereas they were expressed in the whole lobule
of b-catenin-activated livers. If the GS, Glt1, and Oat
proteins belong to the same glutamine metabolic path-
way, Lect2 does not.
Consequently, we wondered whether b-catenin sig-
naling could be a pathway involved in liver zonation.
We show that Apc plays a key role in this zonation by
spatially controlling the activation level of the b-catenin
pathway in the liver. We also demonstrate that activating
b-catenin signaling positively controls the PV gene ex-
pression program and simultaneously inhibits the PP
gene expression program. We also show that expres-
sion of the PP program requires Wnt signaling inhibition.
Finally, we show that b-catenin signaling is the master
pathway that controls nitrogen metabolism in the liver,
and that after Apc loss, the forced expression of the
PV program and the deficient PP program caused se-
vere metabolic perturbation, which kills the mice.
Results
Zonation of Key Molecules Participating
in the Wnt/b-Catenin Pathway in the Liver
We first investigated whether a physiological Wnt/
b-catenin signaling was involved in liver zonation by ana-
lyzing by immunohistochemistry the expression of two
partners of this signaling pathway: b-catenin and the
product of the tumor suppressor gene Apc (Figure 1).
As expected, we observed staining for b-catenin at the
hepatocyte membrane. This is consistent with b-catenin
being part of the adhesion complex in every hepatocyte
(Figure 1A). We specifically observed stronger b-catenin
membrane staining in the entire PV compartment, with
a small amount of b-catenin accumulating in the cytosol
in some cells (Figure 1A, PV and PP). We next investi-
gated whether this increased b-catenin staining was
due to activation of the Wnt/b-catenin pathway by using
an antibody directed against the unphosphorylated
form of b-catenin (Figures 1B and 1C). This antibody re-
veals the stabilized form of b-catenin, which plays a role
in signaling (Murtaugh et al., 2005; van Noort et al.,
2002). We found active b-catenin signaling in all of the
PV hepatocytes, both in the GS-positive proximal PV
area and in the distal PV part (Figures 1B and 1C).
We then looked for the negative regulator Apc. As Apc
immunostaining is difficult to achieve (Brocardo et al.,
2005), we used a new antibody (Spring Bioscience)
directed against the C-terminal part of the protein andchecked its staining specificity in the liver (Figure S1;
see the Supplemental Data available with this article
online). We detected Apc only in the complementary
PP compartment of the liver lobule opposite the PV
compartment (Figure 1D).
Therefore, this complementary distribution of acti-
vated b-catenin in the PV area and Apc in the PP zone
strongly suggests that the b-catenin pathway may oppo-
sitely affect the genetic program of these two domains.
Figure 1. Complementary Immunolocalizations for Activated b-Cat-
enin and Apc Proteins in Perivenous and Periportal Hepatocytes
(A–F) (A) b-catenin immunostaining at the membranes of hepato-
cytes from the whole hepatic lobule. On the left: this staining
increased in hepatocytes from the PV half of the lobule, surrounding
the centrilobular vein (cv). On the right: the inset with an enlarged
view of PV hepatocytes shows increased staining and a faint cyto-
solic accumulation of the protein (arrowhead); the inset with an en-
larged view of PP hepatocytes shows a bile duct (arrow) and weak
staining in hepatocyte membranes. (B, C, and E) PV staining for (B
and C) unphosphorylated b-catenin and (E) GS, which is a marker
of the proximal PV hepatocytes. Note that the staining for unphos-
phorylated b-catenin is mainly cytoplasmic, is not clearly detected
in the nucleus, and that it encompasses the entire PV compartment,
extending from the GS-positive area. (D and F) PP staining for (D)
Apc protein and (F) Pepck1 protein, which is the most commonly
used marker for proximal PP hepatocytes. Note the overlap between
Apc and Pepck1 protein staining. Cv = centrilobular vein; ps = portal
space. The scale bars are 200 mm and 50 mm for PV and PP insets,
respectively, and 100 mm for (C).
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761Figure 2. Tamoxifen-Inducible Liver-Targeted Apc Knockout, Apc koliv Mice
(A) PCR analysis of liver DNA from double transgenic Apclox/lox/TTR-CreTam mice: time course of loss of the 14th exon of Apc (ApcD14) from the
Apc floxed allele (Apclox) 2, 4, 8, 12, and 16 hr (H2, H4, H8, H12, H16) and 1, 2, and 3 days (D1, D2, D3) after intraperitoneal injection of 1 mg
Tamoxifen. Note the nonspecific band (ns) below that of the Apclox allele (at 1500 nt). The ApcD14 band is at 400 nt. Note the intensity of the
PCR band for the ApcD14 allele and the absence the Apclox allele from H16, demonstrating that excision of the 14th exon of Apc 14th is completed
by this time. Days 4, 5, 6, 7, and 8 and after day 10 (D4, D5, D6, D7, D8, D > 10) are the different time points at which the phenotype was studied.
(B) Hyperproliferative hepatomegaly in Apclox/lox/TTR-CreTam mice: the gray bars represent Tam-injected Apclox/lox/TTR-CreTam mice (KO),
whereas the white bars represent either Tam-injected Apclox/+/TTR-CreTam or Tam-injected Apclox/lox control mice (Ctrl) presenting an indistin-
guishable phenotype. Note the mild proliferation detected in controls injected with Tam due to the high dose of Tam used, which is negligible
compared to the intense proliferation seen after Apc knockout. The semiquantitative score of BrdU-positive hepatocytes is as follows: 2, less
than 0.01%; +2, from 0.01% to 0.2%; +, from 0.2% to 1%; ++, from 1% to 5%; +++, from 5% to 15%. The semiquantitative mitotic index is as
follows: 2, less than 0.01%; +2, from 0.01% to 0.2%; +, from 0.2% to 1%; ++, from 1% to 3%; +++, from 3% to 6%. *p < 0.05.
(C) Costainings for BrdU (black staining, DAB+Nickel) and GS (brown staining, DAB substrate) on D3 Apc koliv and control livers; arrows indicate
BrdU-stained hepatocytes, and arrowheads indicate hepatocytes costained for BrdU and GS. The scale bars are 50 mm.
(D) Immunostaining for Apc and GS after Apc loss in the liver. GS and Apc immunostaining in Tam-injected control mice at each time point was
indistinguishable from day 0 and day 2 Apc koliv mice (data not shown). The scale bars are 200 mm.
Error bars represent standard deviations.Immediate Effects of Apc Loss in a Cre-LoxP
Tamoxifen-Inducible Mouse Model
We then designed a model to control both the spatial
and temporal inactivation of the Apc gene. For this, we
crossed conditional mutant mice for Apc (Colnot et al.,
2004a) with TTR-CreTam mice that specifically express
an inducible Cre recombinase in the liver (Tannour-
Louet et al., 2002). The Apclox/lox mice transgenic for
TTR-CreTam were injected with a single dose of 1 mg
Tamoxifen (Tam) (Figure 2A). PCR analysis of liver DNA
showed that recombination began 4 hr after the Tam
injection and was complete after 16 hr. These mice will
hereafter be called Apc koliv. Consistent with our previ-
ous model of Cre adenovirus-mediated invalidation of
Apc (Colnot et al., 2004a), 95% of the Apc koliv animalsdied between 10 and 15 days after Tam injection, after
developing an intense and progressive hepatomegaly
(Figure 2B). We demonstrated a link between this hepa-
tomegaly and hyperproliferation: we detected a sig-
nificant increase in the hepatocellular proliferation rate
from day 3 in Apc koliv livers, after which we detected
numerous mitosis and BrDU-stained cells (Figure 2B).
This proliferation rate was maximal at day 4, and it per-
sisted to a lesser extent until day 8.
This time-controlled Apc inactivation system allowed
us to follow the progressive disappearance of Apc pro-
tein inApc koliv livers (Figure 2D). On day 3 and day 4, we
observed strong staining in the PP area for the Apc pro-
tein. This staining decreased from day 5 onward and
was almost completely abolished by day 6. However,
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we observed an increase in staining for GS, a marker of
the proximal PV compartment, which is also a transcrip-
tional target of b-catenin signaling (Cadoret et al., 2002;
Kruithof-de Julio et al., 2005; Loeppen et al., 2002). GS
expression, seen in the proximal PV area at day 0 (not
shown) and day 2 (Figure 2D), was also seen in the distal
PV area at day 3. We detected extension into the PP
compartment at day 4 and day 5, and all of the hepato-
cytes of the lobule were stained for GS by day 6. This in-
creased area of staining for GS was not due to a prolifer-
ative expansion of the PV compartment, as proliferation
occurred in the whole liver parenchyma, in GS-express-
ing PV cells and GS-deprived PP cells (Figure 2C). Our
data suggest that there is an Apc expression gradient
in the normal liver, and that expression is not detectable
in the PV area and becomes stronger in the entire PP
area. This expression can negatively control the expres-
sion of b-catenin-responsive genes, suggesting that the
portocentral axis is under the control of the b-catenin
pathway.
Activating the b-Catenin Pathway in the Liver
Imposes a Perivenous Genetic Program
to the Whole Lobule
We analyzed the role of b-catenin signaling on both the
PV and PP genetic program with microarrays containing
24,100 cDNAs. We disrupted Apc expression by an
intravenous injection of 109 pfu of Cre adenovirus in
both Apclox/lox and Apc+/lox mice, and we compared
the transcriptome of Apc2/2 hepatomegalic livers to
Apc+/2 livers from control mice (Table S1). The complete
data sets are available in Table S2. We applied two crite-
ria to the array data set: at least a 2-fold differential ex-
pression and a p value < 0.001. This defined a small
set of genes, corresponding to 63 distinct known genes
(Table S1). Among the 32 induced genes, 4 were known
to be expressed in the PV compartment and encoded
the proteins Glt1, GS, Oat, and the arginine vasopressin
receptor 1A (Avpr1A) (Cadoret et al., 2002; Kuo et al.,
1991; Moorman et al., 1988; Tordjmann et al., 1998).
Among the 31 suppressed genes, 2 had been described
as being expressed in the PP compartment and en-
coded the Glutaminase2 (Gls2) and Arginase1 (Arg1)
proteins (Haussinger, 1983; Yu et al., 2003). For the re-
maining 57 genes, there have been no descriptions of
their localization in the liver.
We extracted these zonated genes from the micro-
array list and used real-time quantitative RT-PCR
(qPCR) to validate them in Tam-injected Apc koliv livers
(Table 1; Figure S2). All were confirmed as early targets
of a b-catenin signal in Tam-injected Apc koliv livers: the
PV genesGS,Glt1, andOatwere induced as early as day
3 afterApc invalidation, and theAvpr1A gene was signif-
icantly induced at day 4 (Figure S2). The PP genes Arg1
and Gls2 were substantially reduced as early as day 3.
The microarray analysis was unable to reveal the up-
regulation of several PV genes: the chemotaxin Lect2,
a direct b-catenin/TCF transcriptional target (Ovejero
et al., 2004) excluded by statistical tests, was signifi-
cantly induced in Tam-injected Apc koliv livers as early
as day 3 (Table 1; Figure S2). The RhBg gene, which en-
codes an ammonium transporter, was not spotted on
the array but, as suggested by Schwartz’s group (Stahlet al., 2005), was an early and sensitive marker of a
b-catenin signal in Apc koliv livers (Table 1; Figure S2).
There were also several genes not spotted on the micro-
array that are well known to be periportal: the Cps1 and
Pepck1 genes were significantly repressed as early as
day 4 in Apc koliv livers (Table 1; Figure S2).
Finally, we focused on two genes not known to un-
dergo zonation but which were clearly overexpressed
in the microarray analyses (Table 1). Axin2 is a well-
known direct target of b-catenin/TCF signaling in both
intestinal and liver cancers (Lustig et al., 2002), and
RNase4 has been previously identified as a putative b-
catenin gene in the liver (C.P., unpublished substractive
hybridization data). We confirmed the induction of axin2
and RNase4 mRNAs by qPCR analyses (Table 1; Fig-
ure S2). In situ hybridization confirmed that these targets
were expressed in the PV hepatocytes in normal livers
(Figure 3A), again confirming the close link between
b-catenin signaling activation and PV gene expression
in the normal liver.
We investigated whetherApc loss had the same effect
as b-catenin gain of function by analyzing the level of ex-
pression of the zonated genes identified by microarray
analysis in two other mouse models expressing acti-
vated mutants of b-catenin in the liver—transgenic
mice overexpressing the DN131-b-catenin mutant (Ca-
doret et al., 2002) (Table 1) and mice infected with an ad-
enovirus encoding the S37A-b-catenin mutant (Ovejero
et al., 2004) (Figures 4B and 4D; Table 1). All of the genes
respond similarly toApc loss and to b-catenin-activating
mutations. Thus, Apc controls the zonation of gene ex-
pression through its role as a negative regulator of the
b-catenin pathway.
We then analyzed in situ the expression pattern of dif-
ferent PV and PP genes after the gradual loss of Apc in
the hepatic lobule. In situ hybridization (Figures 3A and
3C) and immunohistochemistry experiments (Figures
3B and 3D) were carried out at different time points in
Apc koliv livers. We observed two expression patterns
for PV genes and proteins (Figures 3A and 3B, at D0):
GS as well as RhBg, Glt1, and Lect2 were expressed
in the proximal PV compartment, whereas Axin2 and
RNase4 were expressed in both the proximal and distal
PV area. After Apc loss, the expression of all of these
PV genes progressively extended toward the PP com-
partment. By day 4, the PP compartment was com-
pletely invaded by the more distal PV genes (Rnase4
andAxin2), and by day 7, the PP compartment was com-
pletely invaded by the proximal PV genes (GS, RhBg,
Glt1, and Lect2) (Figures 3A and 3B).
For the PP program, we observed three expression
profiles in the normal liver (Figures 3C and 3D, at D0):
Gls2 and Pepck1 were expressed in the proximal PP
compartment;Arg1 had a wider PP expression, comple-
mentary to that of the PV gene RNase4; and Cps1 ex-
pression extended into the PV compartment, comple-
mentary to that of the proximal PV gene GS. After Apc
loss, Gls2, Arg1, and Cps1 were strongly repressed as
early as day 3, and Gls2 and Arg1 mRNA were totally
absent from the liver by day 7 (Figure 3C). Pepck1 and
cps1 protein levels decreased from day 4 onward and
had effectively disappeared by day 7 (Figure 3D).
Therefore, we showed that simultaneous induction of
the PV genetic program and repression of the PP
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763Table 1. Zonated Liver Genes Responding to a b-Catenin Signal in Mice
References for a
Zonated Expression
Pattern in the Liver Symbol Gene Apc koliv Liver at Day 7b
DN131 or S37A
b-Catenin-
Expressing Liver
AdCre
Infected
Tamoxifen
Injected
cDNA Microarray qRT-PCRa SSH
Perivenous Expression
Ammonia metabolism
and transport
Moorman et al. (1988) Glul Glutamine synthetase (GS) 8.0 5.3 Induced, ref1
Cadoret et al. (2002) Slc1a2 Glutamate transporter 1
(GLT1, EAAT2)
13.9 8.8 Induced, ref1
Kuo et al. (1991) Oat Ornithine aminotransferase 3.6 11.9 Induced, ref1
Weiner and Verlander
(2003)
Rhbg Rhesus blood
group-associated B
glycoprotein
Not spotted 16.7 NF
Chemotaxis
Ovejero et al. (2004) Lect2 Leukocyte cell-derived
chemotaxin 2
3.7c 4.1 Induced, ref2
Receptor
Tordjmann et al. (1998) Avpr1a Arginine vasopressin
receptor 1A
2.7 1.22 2.14
at day 4
NF
Wnt signaling
Figure 4 Axin2 Axin 2 8.6 7.7 NF
Other functions
Figure 4 Rnase4 Ribonuclease 4 3.8 2.7 Induced, NP
Periportal Expression
Ammonia and urea
metabolism
Watford and Smith (1990) Gls2 Glutaminase2, liver 0.21 0.08 ND
Yu et al. (2003) Arg1 Arginase1, liver 0.14 0.17 ND
Moorman et al. (1988) Cps1 Carbamoyl phosphate
synthetase 1
0.40c 0.44 ND
Carbohydrate metabolism
Bartels et al. (1989) Pck1 Phosphoenolpyruvate
carboxykinase 1, cytosolic
0.62c 0.22 ND
NF = not found; ND = not determined; NP = not published.
a Detailed data for kinetics of expression in Tam-injectedApc koliv livers are presented in Figure 3; ref1 = Cadoret et al. (2002), ref2 = Ovejero et al.
(2004).
b Results are expressed as fold changes, relative to AdCre-infected or Tam-injected control mice.
c Not significant in microarray analysis.program are immediate consequences of Wnt/b-catenin
signaling activation resulting from Apc loss in the liver.
Blocking b-Catenin Signaling in Normal
Liver Converts Perivenous Hepatocytes
to a Periportal Phenotype
We next investigated the consequences of blocking
Wnt/b-catenin signaling in the liver to confirm the role
of the Wnt/b-catenin pathway in liver zonation. We
infected wild-type mice with AdDkk1, an adenovirus
encoding the Dickkopf-1 (Dkk1) protein. Dkk proteins
are well known extracellular antagonists of Wnts that
act by blocking the intracellular Wnt/b-catenin signaling
cascade. We checked that Dkk1 was correctly ex-
pressed in the entire liver, was secreted, and was active
(Figure S4). As previously described (Kuhnert et al.,2004), mice died from major intestinal defects 7 days af-
ter AdDkk1 infection, due to defective Wnt signaling in
the intestine (Figure S4). Therefore, we analyzed their
livers 6 days after infection and observed no macro-
scopic or histological phenotype. However, major mo-
lecular hepatic changes occurred in Dkk1-expressing
hepatocytes (Figure 4). For PV genes, such as RhBg,
Lect2, GS, and Axin2, we observed a large decrease in
the amount of staining in the PV hepatocytes (Figure 4A),
which was supported by a large decrease in mRNA
levels (Figure 4B). We observed the same for the other
centrilobular genes, Oat, Glt-1, and Avpr1a (Figure 4B).
By contrast, we observed staining of PP markers in the
whole lobule of AdDkk1 livers, including the centrilobu-
lar area (Figure 4C). This was confirmed by an increased
transcription of these PP genes, which are Arg1, Gls2,
Developmental Cell
764
Apc Is the Liver ‘‘Zonation-Keeper’’
765and Pepck1 (Figure 4D). This was also confirmed by an
increase in Gls2, Pepck1, and Arg1 mRNA levels in
AdDkk1 livers (Figure 4D).
The layer of hepatocytes in contact with the centrilob-
ular vein still expressed GS in a few cells (Figure 4A,
inset). Moreover, there was weak de novo Arg1 expres-
sion in this area (Figure 4C, inset). This suggests that this
proximal PV area is partially sensitive to Dkk1-mediated
inhibition of Wnt signaling.
Taken together, these results show that Wnt signaling
inhibition is required for developing the periportal pro-
gram and is able to impair b-catenin signaling in the
PV compartment, except for its most proximal part.
Wnt/b-Catenin Signaling Is a Master Pathway
for Nitrogen Metabolism
Among the 13 zonated genes retained (Table 1) as tar-
gets of b-catenin signaling, 7 were related to nitrogen
metabolism. Our results showed that the reciprocal dis-
tribution of the partners of the urea cycle in the PP area
(Arg1, Gls2, Cps1) and of the glutamine scavenger sys-
tem in the PV area (GS, Oat, Glt1) was, respectively,
strongly dependent on negative and positive b-catenin
signaling activity (Figures S2–S4). Such a metabolic
zonation was proposed by Haussinger et al. (1992),
who described a conserved structural and functional
heterogeneity of nitrogen metabolism in the liver of
most ureotelic animals. We analyzed different biological
parameters to investigate whether b-catenin signaling
could be the master regulator of nitrogen metabolism
and whether a disorder linked to this metabolism could
explain the lethality of Tam-injected Apc koliv animals.
We first analyzed liver dysfunction in day 10 Tam-
injected Apc koliv mice by measuring ammonia and
amino acid levels in the liver and blood (Figures 5A
and 5B; Figure S3). Both glutamine and ammonia were
dramatically increased in liver and blood, and uremia
was decreased 2-fold (Figures 5A and 5B). These bio-
chemical alterations could be explained by the genetic
misexpressions observed in Tam-injected Apc koliv
livers that are presented in Figure 5D. Briefly, the smaller
commitment of NH4
+ ions to the urea cycle, combined
with a greater commitment of these NH4
+ ions to gluta-
mine synthesis, led to deficient ammonium detoxifica-
tion and to glutamine accumulation.
Although we cannot exclude other metabolic defects,
two critical biochemical changes could explain the
death of the Apc koliv animals (Figure 5B): the severe hy-
perammonemia, being 4.4 times higher in Apc koliv mice
than in controls, and the severe hyperglutaminemia, be-
ing 26 times higher inApc koliv mice than in controls. The
consequences are that NH4
+ ions and glutamine were
also found at increased levels in the brains of Apc koliv
mice (Figure 5C): this is known to be deleterious (Butter-
worth, 2002) and strongly suggests that these mice
developed a fatal hepatic encephalopathy, which is a
well known cause of death in infants with congenital
urea cycle disorders (Saudubray, 2002).Discussion
In this study, we used the distribution of key partners of
theb-catenin pathway within the liver lobule and the anal-
ysis of the immediate molecular and biochemical conse-
quences of both b-catenin signaling activation mediated
byApc loss and the Dkk1-mediated Wnt signaling block-
ade to show that b-catenin signaling inversely controls
the PV and PP genetic programs in the liver. We provide
compelling evidence that the Wnt/b-catenin pathway
plays a major role in the mechanisms underlying the re-
ciprocal aspects of liver zonation along the portocentral
axis. Among the different zonated functions of the liver,
our results clearly show that nitrogen metabolism is un-
der the control of the b-catenin pathway.
Apc Is the ‘‘Zonation-Keeper’’ Gene of the Liver
Our data show that the tumor suppressor gene Apc is
a key partner of b-catenin signaling for regulating liver
zonation. First, Apc accumulates in the PP compart-
ment, in which there is no b-catenin signaling. Second,
Apc protein could not be detected in the PV compart-
ment, whereas the active form of b-catenin is expressed
with different positive b-catenin target genes. Third, the
loss of Apc from the hepatic parenchyma causes the im-
mediate de novo expression of b-catenin-positive PV
target genes and the simultaneous suppression of
b-catenin-negative PP target genes. This pivotal role
for Apc in controlling b-catenin signaling along the por-
tocentral axis is similar to what occurs along the crypt-
villus axis in the intestine. Indeed, Apc is not found in
the proliferative crypt compartment, which is under
positive control by Wnt/b-catenin signaling, whereas it
is expressed at high levels in the differentiated villus
compartment, in which the b-catenin/TCF program is
suppressed (Smith et al., 1993; van de Wetering et al.,
2002). This is supported at the molecular level in the
EphB/ephrin-B system: b-catenin signaling inversely
controls the expression of the EphB receptors and their
ligand, ephrin-B1, along the crypt-villus axis of the small
intestine, thus controlling the position of the cell popula-
tions of this epithelium (Batlle et al., 2002). Apc not only
controls the normal homeostasis of the intestinal epi-
thelium, but its mutation is also a key event in initiating
tumorigenesis (Andreu et al., 2005; Kinzler and Vogel-
stein, 1996; Sansom et al., 2004). Therefore, Apc has
been defined as the gatekeeper of the intestinal epithe-
lium (Kinzler and Vogelstein, 1996). In the liver system,
we observed that Apc similarly plays a key role in main-
taining the complementary PP and PV domains of the
lobule. This Apc-dependent metabolic zonation is cru-
cial for normal liver homeostasis. This is supported by
our data showing that a massiveApc loss in the liver kills
the animals. As well as playing a role in the mature liver,
Apc is a tumor suppressor gene in the liver. Indeed, our
previous data showed that Apc can initiate liver tumor
development when it is mutated in hepatocytes (Colnot
et al., 2004a). Thus, analogous to the intestinal system,Figure 3. Gradual Extension of Perivenous Gene Expression and Concomitant Loss of Periportal Gene Expression after Apc Inactivation
(A and C) In situ hybridization (blue) to Apc koliv livers for (A) PV genes and (C) PP genes; the analyses for GS, Cps1, and Glutaminase2 were
carried out on serial sections and were carried out likewise for Rnase4 and Arginase1.
(B and D) Immunostaining for the PV proteins RhBg, Glt1, and Lect2, made on serial sections (B) and for the PP proteins Cps1 and Pepck1, made
on serial sections (D). The scale bar is 500 mm and 100 mm for the insets.
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766Figure 4. Dramatic Shift from a Zonated Liver to a Periportal-like Liver after Dkk1-Mediated Blockade of Wnt/b-Catenin Signaling
(A–D) (A and C) Immunostaining (for the PV proteins RhBg and Lect2, made on serial sections) or in situ hybridization (for the PV mRNAGS,Axin2
and the PP mRNA Arginase1 and Glutaminase2, made on serial sections) in the livers of wild-type mice infected with AdDkk1 or AdCre (for con-
trols) at 109 pfu/mouse. (A) Note the near absence of lect2 and Axin2, and the net decrease of Rhbg and GS levels in the Dkk1 liver versus the
control. (C)Arginase1 andGlutaminase2 PP mRNAs have invaded the entire lobule. (Insets in [A] and [C]): In situ hybridization (GS and Arginase1)
of proximal PV hepatocytes on near-adjacent sections of AdDkk1-infected livers. (B and D) Quantitative real-time RT-PCR analyses after ade-
novirus-mediated activation of b-catenin signaling by either inactivating Apc (AdCre Apc koliv, lane 2) or expressing a stable mutant of b-catenin
(Adb-catS37A, lane 3), or after adenovirus-mediated blockade of the Wnt pathway by expressing Dkk1 (AdDkk1, lane 4), versus control wild-type
mice infected with Cre adenovirus (AdCreApcWT, lane 1). y axis values are gene expression levels relative to that of AdCreApcWT control livers.
(B) All the PV mRNAs tested increased in the two models of adenovirus-mediated activation of the b-catenin pathway and decreased in AdDkk1-
infected livers. Only Rnase4 expression did not decrease in AdDkk1 livers, because its expression is induced by an adenoviral infection, inde-
pendent of b-catenin signaling (data not shown). (D) All of the PP mRNAs tested decreased in the two models of adenovirus-mediated activation
of the b-catenin pathway and increased in AdDkk1-infected livers, except for Cps1. The numbers of animals used in this study were as follows:
AdCre Apc WT, n = 3; AdCre Apc koliv, n = 4; Adb-catS37A, n = 2; AdDkk1, n = 5. The scale bars are 500 mm and 100 mm for the insets. *p < 0.05.
Error bars represent standard deviations.
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767Figure 5. Perivenous-Forced Phenotype in Apc koliv Hepatocytes
Breeds a Fatal Metabolic Disorder, Due to Ineffective Ammonium
Detoxification and to Glutamine Accumulation
(A–C) Dramatic phenotypic changes after Apc hepatic loss. (A) He-
patic levels of glutamine, NH4
+, ornithine, and glutamate. (B) Blood
glutamine, ammonia, urea, and bicarbonate ions. (C) Brain gluta-
mine and NH4
+, blood pH, pCO2. Apc ko
liv mice (n = 6 for blood
NH4
+, urea, pH, pCO2, and HCO3
2; n = 8 for amino acids; n = 8 for
brain analyses) are depicted with gray bars, and Tam-injected con-
trol mice (n = 7, 10, and 8, respectively) are depicted with white bars.
*p < 0.005; ns = not significant.
(D) Detoxifying ammonium in the liver uses two pathways. The high-
capacity PP urea cycle pathway also has low specificity. NH4
+ and
HCO3
2 ions are committed to the urea cycle via Cps1 in the firstwe propose that Apc is the ‘‘zonation-keeper’’ gene for
the liver parenchyma and is critical for the functional
maturation of the liver.
Control of Gene Expression along the Portocentral
Axis by Wnt/b-Catenin Signaling
The two proximal areas for each PV and PP compart-
ment can be easily defined (Figure 6). In the proximal
PV compartment around the centrilobular vein, the pres-
ence of unphosphorylated b-catenin and the strong
expression of numerous positive liver b-catenin target
genes support active b-catenin signaling. There is
incomplete Wnt signaling in this region, as a few cells
close to the central vein always seems to be unaffected
by DKK1 inhibition. One hypothesis should be that in this
zone the activation of b-catenin signaling may be both
induced by Wnt factors and, in the one-hepatocyte layer
around the central vein, partially induced by a constitu-
tive lack or an insufficient amount of Apc protein. Con-
versely, in the proximal PP compartment in which Apc
is present, b-catenin signaling is suppressed, as all of
the identified negative targets are found in this area
(Figure 6). Thus, the presence of Apc determines the
absence of b-catenin signaling in this zone, as its re-
moval leads to a rapid de novo expression of PV target
genes and a disappearance of PP target genes. The
intermediate distal PV and PP zones undergo more
complex transcriptional regulations. For example, in the
distal PV area, there is only sufficient activated b-catenin
to allow for the expression of some PV target genes,
RNase4 and Axin2 (see Figure 6). The lack of expression
of the positive PV target genes Gs, Lect2, RhBg, and
Glt1 in this particular area may be explained by dosage
effects due to different levels of b-catenin in the different
compartments able to signal within the nucleus. Such
dosage effects have already been proposed by Fodde’s
group: different Apc mutations in ES cells were associ-
ated with distinct amounts of active b-catenin available
in the nucleus for inducing Lef-Tcf transcription (Kiel-
man et al., 2002). Also, Fuchs’s group found dosage
effects in the control of Wnt signaling in skin epithelial
stem cells (Lowry et al., 2005). Alternatively, a specific
combination of cofactors could cooperate with b-cate-
nin/Lef-Tcf factors to transactivate these genes in the
proximal PV area or to repress them in the distal PV area.
The b-Catenin Pathway Has a Major Impact
on the Control of Ammonia Metabolism
Among the different zonated functions of the liver,
ammonia metabolism is the function associated with a
step, and via Arginase1 in the final step, generating urea and orni-
thine. Due to a defect in the PP enzymes in Apc koliv mice, i.e., the
effectors Cps1 and Arginase1 are strongly reduced, the mice accu-
mulate the substrate of these reactions—NH4
+ and HCO3
2—
whereas the final products, urea and ornithine, are decreased. The
other ammonium detoxification pathway is the PV glutamine scav-
enger system, which is highly specific but has a low capacity. Gluta-
mine synthetase commits NH4
+ and glutamate toward glutamine
synthesis. For this, glutamate is indirectly provided from ornithine
by Oat, and its transport is ensured by Glt1. Finally, RhBg is a contro-
versial ammonium transporter (Chambrey et al., 2005). In the Apc
koliv mice, all of the genes involved in the metabolic process linked
to glutamine are upregulated.
Error bars represent standard deviations.
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768stable gene expression zonation. Our findings show that
b-catenin signaling is the determinant of this zonated
function in the liver, as it spatially separates the two dif-
ferent ammonium detoxification systems: the periportal
area devoted to urea formation and the perivenous area
devoted to glutamine synthesis. For the other functions,
such as carbohydrate and xenobiotic metabolisms,
gene expression zonation is dynamic and depends on
varying humoral and environment inputs (Jungermann
and Kietzmann, 1996). We did not find a clear role of b-
catenin signaling in these dynamic zonated functions
in microarray analyses, and these aspects remain to
be analyzed.
Our results suggest a link between a tumor suppres-
sor gene and a metabolic pathway. Although this is a
rather new suggestion, another tumor suppressor
gene, the LKB1 gene, has been shown to control two
disparate cellular processes—cell polarity and the
AMP kinase activity that controls energy metabolism
(Spicer and Ashworth, 2004). Therefore, it is important
to understand whether the metabolic functions con-
trolled by b-catenin signaling participate in liver tumori-
genesis. Many of the negative or positive target genes
that we have isolated are expressed in b-catenin-acti-
vated tumors in both mice and humans (Stahl et al.,
2005), and a large set of these are involved in nitrogen
metabolism and transport (Gs, Glt1, Arginase1, RhBg).
A comprehensive study is needed to determine whether
nitrogen metabolism is altered in patients or mice har-
boring HCCs activated for b-catenin, and to describe
its impact on tumorigenesis.
To conclude, although rare APC mutations have been
found in liver HCCs (Ishizaki et al., 2004; Legoix et al.,
1999; Taniguchi et al., 2002), our findings demonstrate
the critical role of Apc in liver homeostasis. This, to-
gether with the recent data from Jaenish’s group show-
ing that Apc is often lost after global hypomethylation of
Figure 6. Organization of b-Catenin-Mediated Zonation within the
Liver Cell Plate
The areas, the genes, and the proteins corresponding to: in green,
the periportal zone, deprived of b-catenin signaling; and in red, the
perivenous zone activated for b-catenin signaling. The positive
target genes of a b-catenin signaling are followed by a ‘‘+,’’ and
the negative targets are followed by a ‘‘2.’’ The blue area depicts
the zone in which the consequences of Dkk-mediated inhibition of
Wnt signaling can be seen. The stippled zone is that in which Dkk
effects are incomplete.the genome, leading to liver tumors (Holm et al., 2005;
Yamada et al., 2005), suggests that theAPC loss of func-
tion should be investigated in a subset of human HCCs
that are not mutated for b-catenin but that have an acti-
vated b-catenin pathway.
Experimental Procedures
Transgenic Mice Obtention and Care
Mice carrying the two floxed alleles on the 14th exon of the Apc gene
(Colnot et al., 2004a) (here referred to as Apclox/lox) were interbred
with TTR-CreTam mice (Tannour-Louet et al., 2002). The resulting
compound Apclox/+/TTR-CreTam mice were interbred with Apclox/lox
mice to generate Apclox/lox/TTR-CreTam mice. All mice had been
backcrossed at least four times onto the C57Bl6N background. All
reported animal procedures were carried out according to French
government regulations. Mice were housed in conventional con-
ditions.
Adenoviral Infections
Ad5-CMV-cre and Ad5-Dkk1-HA were amplified by Genethon (Evry,
France) and were supplied at 1011 pfu/ml. Ad5b-catS37A was a gift
of Dr. Jan Kitajewski (Columbia University, New York, USA). Diluted
aliquots (109 pfu in 150 ml) were injected into the retroorbital vein of
8-week-old mice after anesthesic inhalation of Isofluran.
Tissue Processing
Unless otherwise mentioned, analyses were carried out on 2-month-
old male mice. Tamoxifen (1 mg) (ICN, France) was diluted in 10 ml
ethanol, adjusted to 100 ml with sunflower oil, and injected intraper-
itoneally (ip) at the indicated times. S phase nuclei were labeled by ip
injection with BrdU (0.1 mg/g body weight, Sigma, France) 2 hrs be-
fore the mice were killed. Mice were killed at mid-day by cervical dis-
location: liver samples were either snap frozen in liquid nitrogen and
stored at280ºC until molecular analyses or were fixed in 4% formol
for 18 hr and then embedded in paraffin. For b-catenin and unphos-
phorylated b-catenin staining, ketamine-xylasine-anesthesized wild-
type mice were perfused intracardiacally with a cold zinc-formalde-
hyde fixative. Liver slices were then postfixed with the same fixative
for 3 hr at 4ºC before immediate paraffin embedding.
Immunostainings
Paraffin-embedded liver sections were treated as previously de-
scribed (Colnot et al., 2004b). Antibodies are described in Supple-
mental Experimental Procedures.
In Situ Hybridization
Nonisotypic in situ hybridization was carried out on paraffin sections
by using DIG-labeled riboprobes (see Supplemental Experimental
Procedures).
RNA Extraction and Real-Time Quantitative RT-PCR
Total RNA was extracted as described elsewhere (Colnot et al.,
2004b). Reverse transcription was carried out by using standard
protocols (Invitrogen, Superscript II reverse transcriptase), and
qPCR was done in duplicate on a LightCycler apparatus by using
the LightCycler-fastStart DNA Master SYBR Green I Kit (Roche Diag-
nostics) and was expressed relative to rplp0 mRNA, as previously
described (Cadoret et al., 2001). PCR primer sequences are avail-
able in Supplemental Experimental Procedures.
Microarray Analysis
We injected two distinct batches of Cre adenovirus into Apclox/lox
mice (three 2-month-old mice for the first batch, and two 5-month-
old mice for the second batch) and Apclox/+ mice (same numbers
of animals) in two separate experiments. The microarray analyses
are described in Supplemental Experimental Procedures.
Supplemental Data
Supplemental Data include Supplemental Experimental Procedures,
Supplemental Tables, and Figures S1–S4 and are available at http://
www.developmentalcell.com/cgi/content/full/10/6/759/DC1/.
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